Suppr超能文献

原发性头颈部血管肉瘤的特征与预后:一项基于监测、流行病学和最终结果计划(SEER)的1250例病例分析

Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.

作者信息

Lee Kevin C, Chuang Sung-Kiang, Philipone Elizabeth M, Peters Scott M

机构信息

Division of Oral and Maxillofacial Surgery, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY, USA.

Department of Oral and Maxillofacial Surgery, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Head Neck Pathol. 2019 Sep;13(3):378-385. doi: 10.1007/s12105-018-0978-3. Epub 2018 Oct 24.

Abstract

Head and neck angiosarcomas (HN-AS) are rare malignancies with a poor prognosis relative to other soft tissue sarcomas. To date, the HN-AS literature has been limited to short reports and single-institution experiences. This study evaluated patients registered with the Surveillance, Epidemiology, and End Results (SEER) program who had been diagnosed with a primary HN-AS. Predictors were drawn from demographic and baseline tumor characteristics. Outcomes were survival months and cause of death. Kaplan-Meier analyses were used to estimate overall (OS) and disease-specific survival (DSS) rates. Cox proportional hazards regression models were used for multivariate analyses. A total of 1250 patients (mean age 73.3 years) were identified, and nearly all lesions (93.5%) were cutaneous. Two- and 5-year OS rates were 47.3% (95% CI 44.3-50.3) and 26.5% (95% CI 23.7-29.3), while 2- and 5-year DSS rates were 66.6% (95% CI 63.6-69.6) and 48.3% (95% CI 44.5-52.1). In the univariate analyses, age, race, tumor grade, tumor size, AJCC stage, SEER historic stage, and surgery were significant predictors of both OS and DSS. Multivariate regression revealed that independent predictors of poor OS and DSS were older age [OS: HR 1.04 (95% CI 1.02-1.05), p < 0.01; DSS: HR 1.03 (95% CI 1.01-1.05), p < 0.01], increased tumor size [OS: HR 1.01 (95% CI 1.01-1.01), p < 0.01; DSS: HR 1.01 (95% CI 1.01-1.02), p < 0.01], and distant disease [OS: HR 2.97 (95% CI 1.65-5.34), p < 0.01; DSS: HR 4.99 (95% CI 2.50-9.98), p < 0.01]. Age, tumor size, and disease extent were determinants of HN-AS survival. When all other factors were controlled, lower histologic grade and surgery did not improve the risk of death.

摘要

头颈部血管肉瘤(HN-AS)是一种罕见的恶性肿瘤,与其他软组织肉瘤相比预后较差。迄今为止,关于HN-AS的文献仅限于简短报告和单机构经验。本研究评估了监测、流行病学和最终结果(SEER)计划登记的诊断为原发性HN-AS的患者。预测因素来自人口统计学和基线肿瘤特征。结局指标为生存月数和死亡原因。采用Kaplan-Meier分析估计总生存率(OS)和疾病特异性生存率(DSS)。采用Cox比例风险回归模型进行多变量分析。共确定了1250例患者(平均年龄73.3岁),几乎所有病变(93.5%)为皮肤病变。2年和5年OS率分别为47.3%(95%CI 44.3-50.3)和26.5%(95%CI 23.7-29.3),而2年和5年DSS率分别为66.6%(95%CI 63.6-69.6)和48.3%(95%CI 44.5-52.1)。在单变量分析中,年龄、种族、肿瘤分级、肿瘤大小、美国癌症联合委员会(AJCC)分期、SEER历史分期和手术是OS和DSS的重要预测因素。多变量回归显示,OS和DSS较差的独立预测因素为年龄较大[OS:风险比(HR)1.04(95%CI 1.02-1.05),p<0.01;DSS:HR 1.03(95%CI 1.01-1.05),p<0.01]、肿瘤大小增加[OS:HR 1.01(95%CI 1.01-1.01),p<0.01;DSS:HR 1.01(95%CI 1.01-1.02),p<0.01]和远处转移[OS:HR 2.97(95%CI 1.65-5.34),p<0.01;DSS:HR 4.99(95%CI 2.50-9.98),p<0.01]。年龄、肿瘤大小和疾病范围是HN-AS生存的决定因素。当控制所有其他因素时,较低的组织学分级和手术并不能降低死亡风险。

相似文献

2
Head & neck acinar cell carcinoma: a population-based study using the seer registry.
BMC Cancer. 2020 Jul 8;20(1):631. doi: 10.1186/s12885-020-07066-y.
3
Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment outcomes.
Oral Oncol. 2015 Dec;51(12):1088-94. doi: 10.1016/j.oraloncology.2015.08.012. Epub 2015 Oct 9.
4
Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.
JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):470-7. doi: 10.1001/jamaoto.2015.0340.
7
Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
World Neurosurg. 2017 Aug;104:346-355. doi: 10.1016/j.wneu.2017.04.118. Epub 2017 Apr 27.
8
Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
Spine J. 2017 May;17(5):645-655. doi: 10.1016/j.spinee.2016.11.002. Epub 2016 Nov 14.
10
Ewing Sarcoma of the Head and Neck.
Ann Otol Rhinol Laryngol. 2017 Mar;126(3):179-184. doi: 10.1177/0003489416681322. Epub 2017 Jan 5.

引用本文的文献

1
Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies.
Front Oncol. 2025 Jul 1;15:1623327. doi: 10.3389/fonc.2025.1623327. eCollection 2025.
3
Personalized Treatment for Scalp Angiosarcoma.
J Clin Med. 2025 Feb 14;14(4):1278. doi: 10.3390/jcm14041278.
4
A 37-Year Retrospective Analysis Reveals a High Rate of Cutaneous Angiosarcoma of the Scalp in Okinawa, Japan.
Cancer Sci. 2025 Apr;116(4):1059-1067. doi: 10.1111/cas.16453. Epub 2025 Jan 16.
5
Angiosarcoma: clinical outcomes and prognostic factors, a single-center analysis.
J Cancer Res Clin Oncol. 2024 Jun 25;150(6):326. doi: 10.1007/s00432-024-05835-x.
7
Case Report: A rare case of multicentric angiosarcomas of bone mimicking multiple myeloma on F-FDG PET/CT.
Front Med (Lausanne). 2023 Nov 28;10:1330341. doi: 10.3389/fmed.2023.1330341. eCollection 2023.
9
Primary angiosarcoma of the ascending colon diagnosed after the discovery of intraoral tumor.
Clin J Gastroenterol. 2023 Apr;16(2):193-197. doi: 10.1007/s12328-022-01745-y. Epub 2022 Dec 20.
10
Cutaneous Angiosarcoma of the Head and Neck-A Retrospective Analysis of 47 Patients.
Cancers (Basel). 2022 Aug 8;14(15):3841. doi: 10.3390/cancers14153841.

本文引用的文献

1
Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor.
Front Oncol. 2018 Mar 2;8:46. doi: 10.3389/fonc.2018.00046. eCollection 2018.
2
Cutaneous angiosarcoma: update on biology and latest treatment.
Curr Opin Oncol. 2018 Mar;30(2):107-112. doi: 10.1097/CCO.0000000000000427.
4
Survival outcomes for cutaneous angiosarcoma of the scalp versus face.
Head Neck. 2017 Jun;39(6):1205-1211. doi: 10.1002/hed.24747. Epub 2017 Apr 11.
5
6
A prognostic model for resectable soft tissue and cutaneous angiosarcoma.
J Surg Oncol. 2016 Oct;114(5):557-563. doi: 10.1002/jso.24352. Epub 2016 Jul 4.
7
Angiosarcoma of the Head and Neck.
Int Arch Otorhinolaryngol. 2015 Jul;19(3):191-5. doi: 10.1055/s-0035-1547520. Epub 2015 Mar 10.
8
Angiosarcoma of the scalp and face: the Mayo Clinic experience.
JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):335-40. doi: 10.1001/jamaoto.2014.3584.
9
Prognostic features in angiosarcoma of the head and neck: a retrospective monocenter study.
J Craniomaxillofac Surg. 2014 Dec;42(8):1623-8. doi: 10.1016/j.jcms.2014.05.002. Epub 2014 May 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验